GlaxoSmithKline generated approximately 9.3 billion U.S. dollars from vaccine sales in 2021, making it the sixth largest vaccine company in the world based on revenue. Before the pandemic and the appearance of COVID-19 vaccines, the British pharmaceutical giant used to be the global leader in vaccines.
Analyzing vaccine sales of leading companies
GlaxoSmithKline reported an annual revenue of 34.1 billion British pounds in 2021 – vaccine sales accounted for around 20 percent of that figure. Year-on-year sales of Shingrix, the company’s shingles vaccine, more than doubled to almost two billion British pounds in 2020. The leading vaccine of Merck & Co. is Gardasil/Gardasil 9, which can help in the prevention of certain cancers. The vaccine is one of Merck’s top-selling products and accounted for more than half of the company’s total vaccine sales. Pfizer generated vaccine sales of nearly 43 billion U.S. dollars in 2021, of course heavily boosted by its COVID-19 vaccine sales. The pneumococcal vaccine Prevnar 13/Prevenar 13 was the company’s second product based on revenue during that year.
The race for a coronavirus vaccine
Until recently, and despite growth in the global vaccine market, there were only four big pharma companies with substantial vaccine operations. However, the COVID-19 pandemic has highlighted the critical importance of vaccine research and development. Aided by government funding and partnerships, several smaller companies were among the first to enter the race to find vaccines and treatments for the disease. Biotech company Moderna, by applying its pioneering mRNA research to the problem, was among the first to bring a safe and effective COVID-19 vaccine to the broader market.
Leading companies based on global vaccine revenue in 2021
(in billion U.S. dollars)
Characteristic
Revenue in billion U.S. dollars
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
FiercePharma. (October 17, 2022). Leading companies based on global vaccine revenue in 2021 (in billion U.S. dollars) [Graph]. In Statista. Retrieved September 01, 2024, from https://www.statista.com/statistics/1104110/top-global-pharma-companies-by-vaccine-revenue/
FiercePharma. "Leading companies based on global vaccine revenue in 2021 (in billion U.S. dollars)." Chart. October 17, 2022. Statista. Accessed September 01, 2024. https://www.statista.com/statistics/1104110/top-global-pharma-companies-by-vaccine-revenue/
FiercePharma. (2022). Leading companies based on global vaccine revenue in 2021 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: September 01, 2024. https://www.statista.com/statistics/1104110/top-global-pharma-companies-by-vaccine-revenue/
FiercePharma. "Leading Companies Based on Global Vaccine Revenue in 2021 (in Billion U.S. Dollars)." Statista, Statista Inc., 17 Oct 2022, https://www.statista.com/statistics/1104110/top-global-pharma-companies-by-vaccine-revenue/
FiercePharma, Leading companies based on global vaccine revenue in 2021 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1104110/top-global-pharma-companies-by-vaccine-revenue/ (last visited September 01, 2024)
Leading companies based on global vaccine revenue in 2021 (in billion U.S. dollars) [Graph], FiercePharma, October 17, 2022. [Online]. Available: https://www.statista.com/statistics/1104110/top-global-pharma-companies-by-vaccine-revenue/